Category: News
Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, for IVD Use in South Korea
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measured Using Oxford Immunotec’s T-SPOT® Technology – is Published by Public Health England and Oxford Immunotec
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell SelectTM Reagent Kit
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses in New COVID Vaccine Trials
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…